Borrowing from the anti-inflammatory properties of olive oil, Penn Engineers used a century-old chemical reaction to redesign ...

No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

Vaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Many patients experience long-lasting health problems after COVID-19. The study aimed to assess 3-year trajectories of a comprehensive set of patient-reported outcome measures (PROMs) in patients ...

Added value of this study To the best of our knowledge, this study is the largest randomised clinical trial assessing the effect of hydroxychloroquine versus placebo added to a standard of care ...

There will probably never be a perfect treatment to cure COVID-19—but the right medications for the right patients can save lives.

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Novel Coronavirus (COVID-19) : Coronavirus : The explosive rise in cases of coronavirus infection is of concern worldwide. Stay up-to-date here.

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's ...

According to a study published in JAMA Network Open, 70% of U.S. adults would conduct a home test for suspected COVID-19.